This announcement and the fact it’s for gastric cancer with HerVaxx is pure genius by LC and team. It’s clear they are looking at knocking it out of the park. If it works, IMU holds all the cards and not Merck and Pfizer.
We currently hold the IP license in Japan for gastric cancer and HerVaxx. expect if this starts to look good in early stage trials for us to either look for more patients or Merck and Pfizer to come knocking for exclusive use in these markets and world wide.
massive pay day and we have them by the balls not the other way round
Ann: Clinical Trial Supply Agreement with Merck KGaA and Pfizer, page-157
-
- There are more pages in this discussion • 96 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
0.005(9.26%) |
Mkt cap ! $433.6M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.9¢ | 5.4¢ | $1.489M | 25.99M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 35252 | 5.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.0¢ | 1753430 | 24 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |